Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The principle objective of the trial is to compare rosiglitazone to gliclazide in patients
with type 2 diabetes mellitus and chronic stable angina to see how the subjects' angina
status changes.
Angina status will be measured via exercise tolerance testing, 24-hour ECG testing and angina
quality of life questionnaire.